These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

285 related articles for article (PubMed ID: 36747547)

  • 1. Identification and validation of a five-gene prognostic signature based on bioinformatics analyses in breast cancer.
    Du XJ; Yang XR; Wang QC; Lin GL; Li PF; Zhang WF
    Heliyon; 2023 Feb; 9(2):e13185. PubMed ID: 36747547
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Establishment of a N1-methyladenosine-related risk signature for breast carcinoma by bioinformatics analysis and experimental validation.
    Li L; Yang W; Jia D; Zheng S; Gao Y; Wang G
    Breast Cancer; 2023 Jul; 30(4):666-684. PubMed ID: 37178414
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Construction of a prognostic score model for breast cancer based on multi-omics analysis of study on bone metastasis.
    Ren H; Shen X; Xie M; Guo X
    Transl Cancer Res; 2024 May; 13(5):2419-2436. PubMed ID: 38881940
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of a pyroptosis-related prognostic signature in breast cancer.
    Chen H; Luo H; Wang J; Li J; Jiang Y
    BMC Cancer; 2022 Apr; 22(1):429. PubMed ID: 35443644
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A glycolysis-related signature to improve the current treatment and prognostic evaluation for breast cancer.
    Feng S; Ning L; Zhang H; Wang Z; Lu Y
    PeerJ; 2024; 12():e17861. PubMed ID: 39119106
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Construction of mRNA prognosis signature associated with differentially expressed genes in early stage of stomach adenocarcinomas based on TCGA and GEO datasets.
    Jiang F; Lin H; Yan H; Sun X; Yang J; Dong M
    Eur J Med Res; 2022 Oct; 27(1):205. PubMed ID: 36253873
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Construction and validation of a prognostic model based on stage-associated signature genes of head and neck squamous cell carcinoma: a bioinformatics study.
    Chen L; Zhang X; Lin J; Wen Y; Chen Y; Chen CB
    Ann Transl Med; 2022 Dec; 10(24):1316. PubMed ID: 36660709
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of prognostic gene signature associated with microenvironment of lung adenocarcinoma.
    Yue C; Ma H; Zhou Y
    PeerJ; 2019; 7():e8128. PubMed ID: 31803536
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Four-gene signature predicting overall survival and immune infiltration in hepatocellular carcinoma by bioinformatics analysis with RT‒qPCR validation.
    Guan R; Zou J; Mei J; Deng M; Guo R
    BMC Cancer; 2022 Jul; 22(1):830. PubMed ID: 35907846
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Construction of a novel mRNA-signature prediction model for prognosis of bladder cancer based on a statistical analysis.
    Li J; Cao J; Li P; Yao Z; Deng R; Ying L; Tian J
    BMC Cancer; 2021 Jul; 21(1):858. PubMed ID: 34315402
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comprehensive analysis of immune-related gene signature based on ssGSEA algorithms in the prognosis and immune landscape of hepatocellular carcinoma.
    Wang L; Wang L; He P
    Front Genet; 2022; 13():1064432. PubMed ID: 36568383
    [No Abstract]   [Full Text] [Related]  

  • 12. A Novel Inflammatory Response-Related Gene Signature Predicts Immune Status and Prognosis of Breast Cancer.
    Zhao R; Xie C; Gong Y; Wei S; Yuan M; Gan J; Chen W
    J Oncol; 2022; 2022():5468858. PubMed ID: 36467500
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification and Validation of Novel Metastasis-Related Immune Gene Signature in Breast Cancer.
    Ma S; Hao R; Lu YW; Wang HP; Hu J; Qi YX
    Breast Cancer (Dove Med Press); 2024; 16():199-219. PubMed ID: 38634039
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comprehensive
    Xu T; Xu W; Zheng Y; Li X; Cai H; Xu Z; Zou Q; Yu B
    Front Immunol; 2022; 13():931906. PubMed ID: 35958598
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of a 5-Gene-Based Scoring System by WGCNA and LASSO to Predict Prognosis for Rectal Cancer Patients.
    Huang H; Xu S; Chen A; Li F; Wu J; Tu X; Hu K
    Anal Cell Pathol (Amst); 2021; 2021():6697407. PubMed ID: 33833937
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A combined hypoxia and immune gene signature for predicting survival and risk stratification in triple-negative breast cancer.
    Yang X; Weng X; Yang Y; Zhang M; Xiu Y; Peng W; Liao X; Xu M; Sun Y; Liu X
    Aging (Albany NY); 2021 Aug; 13(15):19486-19509. PubMed ID: 34341184
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cuproptosis/ferroptosis-related gene signature is correlated with immune infiltration and predict the prognosis for patients with breast cancer.
    Li J; Zhang W; Ma X; Wei Y; Zhou F; Li J; Zhang C; Yang Z
    Front Pharmacol; 2023; 14():1192434. PubMed ID: 37521466
    [No Abstract]   [Full Text] [Related]  

  • 18. Exploration of prognostic genes and risk signature in breast cancer patients based on RNA binding proteins associated with ferroptosis.
    Chen X; Yang C; Wang W; He X; Sun H; Lyu W; Zou K; Fang S; Dai Z; Dong H
    Front Genet; 2023; 14():1025163. PubMed ID: 36911389
    [No Abstract]   [Full Text] [Related]  

  • 19. Detecting prognostic biomarkers of breast cancer by regularized Cox proportional hazards models.
    Li L; Liu ZP
    J Transl Med; 2021 Dec; 19(1):514. PubMed ID: 34930307
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification and Validation of an Immunological Expression-Based Prognostic Signature in Breast Cancer.
    Pei J; Li Y; Su T; Zhang Q; He X; Tao D; Wang Y; Yuan M; Li Y
    Front Genet; 2020; 11():912. PubMed ID: 33193571
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 15.